CS2 Score (Cardiogenic Shock Survival) Calculator
Patient assessment
Enter admission findings to calculate the CardShock and IABP-SHOCK II scores separately.
Scoring and interpretation
These are two distinct prognostic scores, not a combined “CS2” score. The CardShock score estimates in-hospital mortality in cardiogenic shock of varied aetiologies. IABP-SHOCK II estimates 30-day mortality in AMI-related cardiogenic shock.
CardShock score
| Variable | Criterion | Points |
|---|---|---|
| Age | >75 years | 1 |
| Confusion | Present at presentation | 1 |
| Previous MI or CABG | Present | 1 |
| ACS aetiology | Shock caused by ACS | 1 |
| LVEF | <40% | 1 |
| Blood lactate | 2–4 mmol/L / >4 mmol/L | 1 / 2 |
| eGFR | 30–60 / <30 mL/min/1.73 m² | 1 / 2 |
CardShock risk groups
| Score | Category | Observed in-hospital mortality |
|---|---|---|
| 0–3 | Low | 8.7% |
| 4–5 | Intermediate | 36% |
| 6–9 | High | 77% |
IABP-SHOCK II score
| Variable | Criterion | Points |
|---|---|---|
| Age | >73 years | 1 |
| Prior stroke | Present | 2 |
| Admission glucose | >191 mg/dL | 1 |
| Creatinine | >1.5 mg/dL | 1 |
| Arterial lactate | >5 mmol/L | 2 |
| Post-PCI TIMI flow | Grade <3 | 2 |
IABP-SHOCK II risk groups
| Score | Category | Observed 30-day mortality |
|---|---|---|
| 0–2 | Low | 23.8% |
| 3–4 | Intermediate | 49.2% |
| 5–9 | High | 76.6% |
References and clinical context
Harjola V-P, Lassus J, Sionis A, et al.Clinical picture and risk prediction of short-term mortality in cardiogenic shock. European Journal of Heart Failure. 2015;17(5):501–509. DOI: 10.1002/ejhf.260. PubMed.
Pöss J, Köster J, Fuernau G, et al.Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction. Journal of the American College of Cardiology. 2017;69(15):1913–1920. DOI: 10.1016/j.jacc.2017.02.027. PubMed.
Important limitations
- Risk categories summarize observed outcomes in the original derivation cohorts; they are not a guarantee of an individual patient’s outcome.
- CardShock’s endpoint is in-hospital mortality; IABP-SHOCK II’s endpoint is 30-day mortality. Do not compare the percentages as if they were the same endpoint.
- IABP-SHOCK II was developed in AMI-related cardiogenic shock. Use outside that population requires caution.
- Post-PCI TIMI flow is not an admission variable and may be unavailable before PCI. A missing value is not equivalent to documented TIMI grade 3.
Clinical disclaimer: This calculator is intended to support, not replace, clinical assessment and decision-making. Confirm input values, units, and eligibility for the relevant score. Cardiogenic shock requires urgent assessment and treatment according to the patient’s clinical status and local protocols; do not delay care to calculate a score.
PERSONAL WORKSPACE
Clinical notes
Document key findings and keep a structured record for your own reference.
Private by design. Notes are stored in this browser on this device only. They are not uploaded to Appcardio.
Export or share this note
PERSONAL WORKSPACE
My notes
Review, edit, or remove notes saved in this browser.
Stored locally on this device
QUALITY & SAFETY
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.
Please describe the issue clearly. For calculation concerns, include the input values and expected result where possible.